Protocol Ledger

NCT06524882 · Phase III · RECRUITING

Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age

Interventional Phase III clinical trial protocol NCT06524882 sponsored by Jaeb Center for Health Research in Rare Genetic, Women's Health, and Other, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2024-10-22 Enrollment: 252 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06524882
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)252 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)2 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06524882
Protocol FieldVerified Registry Value
NCT IdentifierNCT06524882
Consolidated Lead SponsorJaeb Center for Health Research
Therapeutic Condition CohortRare Genetic, Women's Health, and Other
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment252 participants (ESTIMATED)
Registered Start Date2024-10-22
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT06524882
Hospital Research SiteLocationSite Profile
University of ArizonaTucson, AZOpen Hospital Dossier ->
Stanford Health Care and Stanford Cancer InstituteStanford, CAOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI